Key facts
- In July 2026, 29 EU/EEA countries reported measles data. Thirteen countries reported 118 cases and 16 countries reported zero cases.
- During the previous 12-month period, zero deaths attributable to measles were reported to ECDC.
- Overall, case numbers decreased compared with the previous month.
- Complementary epidemic intelligence surveillance was performed on 15-16 September 2026. Outbreaks have been reported in Bulgaria and Sweden. Sporadic cases and clusters have been reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA.
Overview
In July 2026, 29 EU/EEA countries reported measles data. Thirteen countries reported 118 cases and 16 countries reported zero cases.
Overall, case numbers decreased compared with the previous month, however, this may be subject to change in the event of a future retrospective update. The highest case counts were reported by Bulgaria (61), Italy (29), Spain (seven), Poland (seven) and Belgium (four).
In the most recent 12-month period, from 1 August 2025 to 31 July 2026, 30 EU/EEA Member States reported a total of 2 339 cases of measles, 2 012 (86.0%) of which were laboratory confirmed
Of the 2 339 cases with known age, 669 (28.6%) were in children under five years; 1 197 (51.2%) cases were in those aged 15 years and above. The highest notification rates were observed among infants under one year (59.3 cases per million) and children aged 1-4 years (28.6 cases per million).
Of 2 052 individuals (87.7% of all cases) with a known age and vaccination status, 1 501 (73.1%) were unvaccinated, 325 (15.8%) were vaccinated with one dose of a measles-containing vaccine, 184 (9.0%) were vaccinated with two or more doses, and 41 (2.0%) were vaccinated with an unknown number of doses.
During the 12-month period, zero deaths attributable to measles were reported to ECDC by any country. Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance was performed on 15-16 September 2026. Outbreaks continue in Bulgaria, and Sweden. Sporadic cases and clusters were reported in several EU/EEA countries. Updates are provided for several countries and regions outside the EU/EEA: England, Ukraine, Africa CDC, the World Health Organization Pan American Health Organization (WHO PAHO), Japan, Canada, the United States (US) and Mexico.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria reported eight confirmed or probable cases in 2026 and as of 9 September 2026 (an increase by one case since June).
Bulgaria has seen a decline in outbreak-related cases, with a total of 555 cases of measles reported by the end of August 2026 (reported on 2 September 2026). The cases have been reported in twelve districts of the country. Most of the cases and highest incidence are reported in Vratsa region (276, 191 000 per 100 000 population), followed by Pleven (163), Lovech (85), Montana (11), Sofia-city (9), Varna (3), Ruse (3), Vidin (1), Pazardzhik (1), Pernik (1), Sofia-region (1) and Targovishte (1). Most of the cases are children (85.6%, 470/555) with the highest incidence among those under one year. Over a half of the cases were not vaccinated due to age limitations or for other reasons (n=283). Immunisation status was unknown for 41 individuals, and others had evidence of immunisation. Since the beginning of the outbreak, 80 213 MMR vaccine doses have been administered in the country. In 2025, Bulgaria reported two cases.
Estonia reported four cases in 2026, as of end of August.
Finland reported one measles case in 2026, as of 15 September 2026.
France reported 113 cases of measles and no deaths from January to August 2026, an increase of 36 cases since end of April 2026. The three most affected age groups are adults aged 40 years and over (15%), adults aged 20-24 years (14%) and children aged 1-4 years (13%). Over half of the cases with known vaccination status (e.g. individuals who are not eligible for vaccination due to age) (41/76, 54%) were unvaccinated, and 35 (46%) individuals were vaccinated with two doses. At least one case was reported in 34 departments of France, with most of the cases reported in Yvelines (10%), Hauts-de-Seine (9%), Moselle (8%), Haute-Savoie (7%) and Paris (7%). No measles cases have been reported in oversees departments and regions.
Germany reported 125 confirmed and probable measles cases in 2026 (week 1 to 36), an increase of 30 cases from week 24.
Lithuania reported ten cases from January to 2 July 2026.
Poland reported 31 cases from 1 January to 31 August 2026.
Portugal reported nine cases from 1 January to end of August 2026, an increase of two cases since 21 May 2026. Of the reported cases, three confirmed cases were imported and three were from Portugal. The origin of the remaining cases is under investigation.
Spain reported 160 cases of measles from 1 January to 13 September 2026, including 15 imported cases.
Sweden Since January 2026 and as of 16 September, 47 cases of measles have been reported, 40 of which are related to the outbreak reported in mid-August, linked to a musical festival (data as of 9 September). The vast majority of affected individuals were unvaccinated school-age children and young adults.
Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:
No new outbreaks or cases have been detected in the reporting period.
Western Balkans countries and Türkiye
No new outbreaks have been detected in the reporting period.
Albania reported 169 cases in from January to June 2026 (provisional WHO data).
Serbia reported two cases of measles from January to July 2026 (provisional WHO data).
Türkiye reported 677 measles cases during January and June 2026, according to provisional
Epidemiological summary for selected countries outside of the EU/EEA with relevant epidemic intelligence updates:
England: between 1 January 2026 and 31 August 2026, there have been 983 laboratory-confirmed measles cases reported in England. The majority (599 out of 983, 61%) of these cases were in children aged 10 years and under, and 51% (501 out of 983) of these cases have been in London. Three deaths have been reported; two children and one adult.
Scotland 13 laboratory-confirmed measles cases have been reported in Scotland in 2026.
Ukraine has reported 627 cases since January 2026 (up until July 2026).
Australia has reported 113 cases in 2026, as of 15 September 2026.
Bangladesh is experiencing a major measles outbreak (WHO DON). According to the Directorate General of Health Services (DGHS), by 14 September 2026 there had been 172 720 suspected measles cases, including 20 124 laboratory-confirmed cases, with 1 030 suspected or confirmed measles-related deaths (100 laboratory-confirmed and 930 suspected). The majority of cases are children under 5 years (79%).
Israel an ongoing measles outbreak has resulted in 3 729 cases, 1 253 hospitalisations and 17 deaths as of 2 September 2026, according to the Israeli Ministry of Health.
Africa CDC reported on 30 August 2026, 9 401 confirmed and 143 222 suspected cases of measles and 1 392 deaths from 23 AU Member State countries, with the Democratic Republic of Congo (102 163 cases and 1 277 deaths), Somalia (11 834 cases and 42 deaths), and Burkina Faso (10 471 cases and 31 deaths) having the highest numbers in terms of case counts.
According to the WHO Pan American Health Organization (WHO PAHO) report published on 7 September, 52 480 confirmed measles cases have been reported by 16 countries, the majority of which have been reported from Guatemala (33 490).
Mexico reported 12 939 confirmed cases of measles and 20 deaths in 2026 and as of 14 September. The number of cases has declined in the last couple of months. Since the start of the outbreak in 2025, Mexico has reported 19 553 confirmed cases of measles and 47 deaths.
Canada reported 1 119 measles cases (1 038 confirmed) and no deaths across nine jurisdictions in 2026 and as of 14 September 2026. The country remains in active transmission across multiple provinces due to an ongoing multi-jurisdictional outbreak, and the vast majority of the cases reported in 2026 are linked to this outbreak.
The US as of September 10, the US has reported 3 294 confirmed measles cases in 47 jurisdictions since January 2026. The majority of cases have occurred in school-age children and adults (82%) and unvaccinated individuals (95%). Pennsylvania is currently experiencing the largest ongoing measles outbreak, reporting a total of 731 cases and four associated deaths (16 September 2026). Over 31% of the reported cases are children under 18 years of age.
For more information on the provisional number of cases outside the EU/EEA region, please visit the World Health Organization (WHO) website.
The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.
Continued vigilance is essential due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, possible introduction from areas with ongoing transmission, and increased travel and population movement during holiday periods.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs of measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.
ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for measles-containing vaccines (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with populations underserved by healthcare services. Systemic barriers that affect vaccine uptake in populations that are isolated and underserved by healthcare services need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
- In light of the summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up-to-date with recommended immunisations prior to departure.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024, and its conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.